Sep 11, 2023 / 06:00PM GMT
Swayampakula Ramakanth - H.C. Wainwright & Co., LLC - Analyst
Good afternoon, and thanks for joining us to have a conversation with Alex Khan, Vice President of Finance and IR of Absci Corporation. Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics.
Absci technology has been validated by generating relationships with companies such as Merck and high-tech company such as NVIDIA. The company has established a proprietary drug creation platform and recently has made the decision to spend more of their resources on internal drug development programs while executing on their partnered active programs.
To discuss the company's development strategy in 2023 and beyond, I welcome Alex to this fireside chat. Alex, glad to see you accepting our invitation to talk to our audience today.
Alex Khan - Absci Corporation - VP, Finance and IR
Well, thank you, RK, and thank you, H.C. Wainwright, for the opportunity. Happy to be here.
Absci Corp at HC Wainwright Investment Conference - New York Transcript
Sep 11, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers